MX2022007212A - Vaccine against infectious bronchitis. - Google Patents

Vaccine against infectious bronchitis.

Info

Publication number
MX2022007212A
MX2022007212A MX2022007212A MX2022007212A MX2022007212A MX 2022007212 A MX2022007212 A MX 2022007212A MX 2022007212 A MX2022007212 A MX 2022007212A MX 2022007212 A MX2022007212 A MX 2022007212A MX 2022007212 A MX2022007212 A MX 2022007212A
Authority
MX
Mexico
Prior art keywords
infectious bronchitis
against infectious
vaccine against
vaccines
adjuvanted
Prior art date
Application number
MX2022007212A
Other languages
Spanish (es)
Inventor
Paul Joseph Dominowski
Freitas Carla Maria Batista De
Santos Maria Carolina Ferreira Dos
Harmen Jacob Geerligs
Original Assignee
Zoetis Services Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc
Publication of MX2022007212A publication Critical patent/MX2022007212A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265—Infectious rhinotracheitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12211—Orthoreovirus, e.g. mammalian orthoreovirus
    • C12N2720/12234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18311—Metapneumovirus, e.g. avian pneumovirus
    • C12N2760/18334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

Poultry vaccines against infectious bronchitis and Turkey Rhinotracheitis are provided. The vaccines are adjuvanted with oil emulsion containing an immunostimulatory oligonucleotide. The methods of using the vaccines are also provided.
MX2022007212A 2016-06-02 2018-11-30 Vaccine against infectious bronchitis. MX2022007212A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662344598P 2016-06-02 2016-06-02
US201662365419P 2016-07-22 2016-07-22

Publications (1)

Publication Number Publication Date
MX2022007212A true MX2022007212A (en) 2022-07-12

Family

ID=59215993

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2018014857A MX2018014857A (en) 2016-06-02 2017-05-31 Vaccine against infectious bronchitis.
MX2022007212A MX2022007212A (en) 2016-06-02 2018-11-30 Vaccine against infectious bronchitis.
MX2022012910A MX2022012910A (en) 2016-06-02 2018-11-30 Vaccine against infectious bronchitis.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2018014857A MX2018014857A (en) 2016-06-02 2017-05-31 Vaccine against infectious bronchitis.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022012910A MX2022012910A (en) 2016-06-02 2018-11-30 Vaccine against infectious bronchitis.

Country Status (16)

Country Link
US (2) US11103573B2 (en)
EP (1) EP3463446A1 (en)
JP (2) JP2019517526A (en)
KR (5) KR20180129926A (en)
CN (1) CN109152829A (en)
AU (1) AU2017274332A1 (en)
BR (1) BR112018075033A2 (en)
CA (2) CA3175832A1 (en)
CL (2) CL2018003420A1 (en)
CO (1) CO2018012905A2 (en)
MX (3) MX2018014857A (en)
PH (1) PH12018502525A1 (en)
RU (1) RU2021117820A (en)
UA (1) UA126562C2 (en)
WO (1) WO2017210244A1 (en)
ZA (3) ZA201807477B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111303252A (en) * 2020-02-17 2020-06-19 青岛易邦生物工程有限公司 Purification method for large-scale production of embryotoxin antigen
WO2024077025A1 (en) * 2022-10-04 2024-04-11 Zoetis Services Llc Poultry vaccines and methods of protecting poultry

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA978434B (en) * 1996-09-27 1998-03-26 Akzo Nobel Nv Inactivated vaccines.
CA2238659C (en) * 1997-05-26 2010-12-14 Akzo Nobel N.V. Recombinant birnavirus vaccine
US6048535A (en) 1997-06-12 2000-04-11 Regents Of The University Of Minnesota Multivalent in ovo avian vaccine
US8088388B2 (en) 2002-02-14 2012-01-03 United Biomedical, Inc. Stabilized synthetic immunogen delivery system
KR101172921B1 (en) 2004-03-12 2012-08-13 와이어쓰 엘엘씨 Infectious bursal disease virus antigenic isolates and vaccines
GB0428394D0 (en) * 2004-12-24 2005-02-02 Chiron Srl Saccharide conjugate vaccines
CN101517082B (en) 2006-09-27 2014-01-22 科勒制药有限责任公司 Cpg oligonucleotide analogs containing hydrophobic t analogs with enhanced immunostimulatory activity
DK2310046T3 (en) 2008-06-27 2016-04-25 Zoetis Services Llc HOW TO UNKNOWN ADJUSTIVE COMPOSITIONS
AR072976A1 (en) * 2008-08-08 2010-10-06 Wyeth Corp ISOLATED INFECTIOUS BRONCHITIS (IB) VIRUSES, VACCINE COMPOSITION AND METHOD TO PREPARE AN INFECTIOUS BRONCHITIS (IB) VIRUS ATTACHED LIVE
CN101721698B (en) 2008-10-24 2014-04-02 法罗斯疫苗公司 Foot-and-mouth disease resistant vaccine composition and preparation and application thereof
PL2376107T3 (en) * 2008-12-09 2014-09-30 Coley Pharm Group Inc Immunostimulatory oligonucleotides
CN102038949A (en) * 2010-12-29 2011-05-04 青岛易邦生物工程有限公司 Method for producing newcastle disease, infectious bronchitis, egg drop syndrome and avian influenza (H9 subtype) combined inactivated vaccine
EP2471926A3 (en) * 2010-12-30 2012-07-11 Intervet International BV Immunostimulatory oligodeoxynucleotides
CN104244973B (en) 2012-11-16 2017-10-20 美国联合生物医学公司 For the urgent vaccine based on synthetic peptide of aftosa (FMD)
CA3005608C (en) 2013-09-19 2020-06-30 Zoetis Services Llc Water-in-oil emulsions comprising immunostimulatory oligonucleotides

Also Published As

Publication number Publication date
EP3463446A1 (en) 2019-04-10
JP2023002541A (en) 2023-01-10
KR20220064417A (en) 2022-05-18
RU2018142329A3 (en) 2020-09-01
CL2018003420A1 (en) 2019-01-18
US20190240315A1 (en) 2019-08-08
KR20180129926A (en) 2018-12-05
KR20220100725A (en) 2022-07-15
US11103573B2 (en) 2021-08-31
CA3175832A1 (en) 2017-12-07
KR20210068601A (en) 2021-06-09
PH12018502525A1 (en) 2019-10-21
KR20210068602A (en) 2021-06-09
CN109152829A (en) 2019-01-04
ZA202204979B (en) 2022-09-28
ZA201807477B (en) 2023-06-28
JP2019517526A (en) 2019-06-24
US20220175911A1 (en) 2022-06-09
CO2018012905A2 (en) 2018-12-14
CA3025524C (en) 2023-03-07
UA126562C2 (en) 2022-11-02
CL2020002876A1 (en) 2021-05-07
CA3025524A1 (en) 2017-12-07
MX2022012910A (en) 2022-11-14
BR112018075033A2 (en) 2019-03-26
ZA202204980B (en) 2022-09-28
RU2018142329A (en) 2020-06-01
RU2021117820A (en) 2021-07-07
WO2017210244A1 (en) 2017-12-07
AU2017274332A1 (en) 2018-11-22
MX2018014857A (en) 2019-03-07

Similar Documents

Publication Publication Date Title
CL2019001640A1 (en) Recombinant hvt vectors expressing multiple avian pathogen antigens and their uses.
MX2018002106A (en) Therapeutic hpv18 vaccines.
PH12015502790A1 (en) Recombinant hvt vectors expressing antigens of avian pathogens and uses thereof
MY181175A (en) Therapeutic hpv16 vaccines
SG11202003800YA (en) Zika vaccines and immunogenic compositions, and methods of using the same
IL263550A (en) Vaccine against infectious bronchitis virus
MX2020005584A (en) Vaccination with replicon particles and oil adjuvant.
NZ739260A (en) Inactivated canine influenza vaccines and methods of making and uses thereof
EP3939604A3 (en) Influenza hemagglutinin protein vaccines
MX2022007212A (en) Vaccine against infectious bronchitis.
MX2018008529A (en) Orthomyxo-like virus of tilapia.
MX2018016306A (en) Duck enteritis virus and the uses thereof.
MX2018014955A (en) Equine influenza virus live-attenuated vaccines.
BR112016001686A2 (en) VACCINE, METHOD FOR PREPARING A VACCINE, COMPOSITION, AND USE OF A COMPOSITION
MX2018000091A (en) Duck enteritis virus and the uses thereof.
EA201792512A1 (en) COMPOSITIONS FOR DELIVERY OF ANTIGENS OF RESPIRATORY SYNTICIAL VIRUS AND NOROVIRUS INTO THE THIN INTESTINE
UY36208A (en) "MODIFIED BACTERIA FOR IMPROVED VACCINES AGAINST BRUCELOSIS".
MX2018003173A (en) Salmonella choleraesuis-salmonella typhimurium vaccines.
AR125960A2 (en) VACCINE FOR USE IN POULTRY AGAINST INFECTIOUS BURSITIS
AU2019268149A1 (en) Live attenuated heterologous vaccine for Leptospira
AR108664A1 (en) VACCINE AGAINST INFECTIOUS BRONCHITIS
AR101124A1 (en) MODIFIED BACTERIA FOR IMPROVED VACCINES AGAINST BRUCELOSIS
EA201992167A1 (en) VACCINE
PH12017502378A1 (en) Inactivated canine influenza vaccines and methods of making and uses thereof